The Infectious Disease Drug Market was valued at US$ 254.73 billion in 2025 and is expected to reach US$ 311.22 billion by 2034. The market is estimated to record a CAGR of 2.25% during 2026–2034. Increasing demand for effective treatments against bacterial, viral, fungal, and parasitic infections, rising infectious disease prevalence, growing healthcare expenditure, and continuous...
